肠道菌群
2型糖尿病
医学
菌群(微生物学)
2型糖尿病
平衡(能力)
炎症
糖尿病
内科学
内分泌学
失调
免疫学
药理学
生物
作者
Bingwei Li,Yuan Li,Bing Wang,Yingyu Wang,Weiqi Liu,Xiang Xu,Mingming Liu,Xu Zhang,Ruijuan Xiu
出处
期刊:Phytomedicine
[Elsevier BV]
日期:2026-01-12
卷期号:151: 157828-157828
被引量:1
标识
DOI:10.1016/j.phymed.2026.157828
摘要
BACKGROUND: The potential for microbial modulation to serve as both a therapeutic and prophylactic strategy against type 2 diabetes mellitus (T2DM)-induced microvasculopathy remains underexplored. We therefore compared the efficacy of the gut-centric herbal formulation Intestinal Flora Balance (IFB, BNFF™), when used for therapeutic reversal, synergistic rescue, or prophylactic protection. METHODS: A murine T2DM model was used to compare three arms, IFB monotherapy, IFB-metformin combination therapy, and IFB pretreatment administered prior to disease induction. Pancreatic and intestinal microcirculation was quantified using in vivo laser Doppler and fiber optic probes. Fecal microbiota composition was analyzed via 16S rRNA gene sequencing. RESULTS: As a therapeutic agent, IFB monotherapy effectively lowered blood glucose and restored microvascular function by reversing diabetic gut dysbiosis. Combination with metformin, while not further improving glycemia, acted synergistically to provide superior rescue of pancreatic microcirculation, indicating complementary modes of action. Prophylactic administration of IFB conferred protection, preserving microbial homeostasis and significantly attenuating the onset of both hyperglycemia and microvascular damage. IFB enhanced the richness and diversity of the intestinal microbiome in T2DM mice and restored the Bacteroidetes/Firmicutes ratio. CONCLUSIONS: By demonstrating that IFB ecologically restores the microbiome, in contrast to metformin's pharmacological modulation, our study provides a new framework for its use as a prophylactic, a restorative monotherapy, or a synergistic partner to build microcirculatory resilience.
科研通智能强力驱动
Strongly Powered by AbleSci AI